Fitzpatrick, House Repeal Medical Device Tax

Bipartisan Majority Protects Patients and Medical Innovation

July 24, 2018

WASHINGTON – Congressman Brian Fitzpatrick release a statement after the House of Representatives overwhelmingly voted to repeal the Medical Device Tax.

“I was proud to advance the bipartisan Protect Medical Innovation Act. Today’s vote fulfills a pillar of the Problem Solvers’ Caucus healthcare agenda that would provide relief to patients and families, while encouraging medical research and development. Moreover, repeal of the medical device tax ensures that the United States continues to be the world leader in healthcare innovation by encouraging further investment in cutting edge medical research and technology while protecting good paying jobs here in Bucks and Montgomery Counties.” 

The bipartisan Protect Medical Innovation Act [H.R. 184], co-sponsored by Fitzpatrick, permanently repeals the Medical Device Tax imposed by the Affordable Care Act effective for sales after December 31, 2019.

Under the Affordable Care Act, beginning in 2013, the manufacturer, producer, or importer of any taxable medical device must pay an excise tax equal to 2.3 percent of the sales price of such device. Congress has previously agreed on a bipartisan basis that this tax is harmful to job creation and innovation by suspending its enactment for 2016 and 2017 and then again for 2018-2019.

The Bipartisan Problem Solvers Caucus included repeal of the Medical Device Tax in their set of principles aimed at stabilizing the health insurance markets and providing relief to individuals, families and small businesses.